NCT06517576
Using Remote Monitoring to Address Health Disparities in Type 2 Diabetes
At risk: Primary completion moved 1 year 4 months later.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary completion pushed from Aug 31, 2025 to Dec 31, 2026
- Eligibility criteria expanded, about 9 words
- Study completion pushed from Sep 30, 2025 to Jan 30, 2027
- Publications: details revised at 3 of 3 entries
- Minor Primary completion date: Jun 2025 to Aug 31, 2025
- Study completion date: Aug 2025 to Sep 30, 2025
- Start date: Dec 5, 2024 to Dec 1, 2024
- Notable Trial status: Not Yet Recruiting to Enrolling by Invitation
- Study sites: 0 to 1
- Start date changed from estimate of Oct 2024 to Dec 5, 2024
- Notable Start date: Aug 2024 to Oct 2024
- Primary completion date: Apr 2025 to Jun 2025
- Study completion date: Jun 2025 to Aug 2025
- Collaborators reordered
- Notable Eligibility criteria shortened, about 11 wordsv2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (8)
Show 3 moreShow less
Arms and interventions
Participants in this group will receive blood glucose monitors and will check their blood glucose daily with monitoring through a digital platform and provided health coaching.
Participants in this group will receive continuous glucose monitors and will self monitor their blood glucose measurements with support by their care team.
Participants in this group will receive standard care for diabetes.
Devices: Blood glucose monitor with Digital Platform and Health Coaching, Continuous glucose monitor
Other: Usual Care
Sites
1 site in 1 country
- Lawndale Christian Health CenterChicago, Illinois, United States